Latest News and Press Releases

AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on November 12, 2024.

AVITA Medical reported third-quarter commercial revenue of $19.5 million, reflecting an approximately 44% increase over the same period last year.

AVITA Medical announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on November 7, 2024.

AVITA Medical to present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 9:10 a.m. Eastern Time.

AVITA Medical will participate in Lake Street Capital Markets’ 8th Annual Best Ideas Growth (BIG8) Conference in New York on September 12, 2024.

AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on August 13, 2024.

AVITA Medical today reported second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year.

AVITA Medical announces industry leader, Robin VanDenburgh, has joined as Senior Vice President of U.S. Commercial Sales, effective August 6, 2024.

AVITA Medical expands portfolio with unique collagen dermal matrix through an exclusive development and distribution agreement with Regenity Biosciences.

AVITA Medical will report its second quarter 2024 financial results after market close on August 8 2024 and host a webcast that day at 1:30 PM PDT.